BetaEval Global: Prospective, Multinational, Observational Cohort Study of Patients Using BETACONNECT<sup>®</sup>.

导出 LinkOut

翻译打印收藏纠错

作者： Francesco,Patti ^[1] ; María Luisa,Martínez Ginés ^[2] ; Christiane,Norenberg ^[3] ; Fernando,Duarte Caron ^[4]

作者单位： Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia; Multiple Sclerosis Center, University of Catania, Catania, Italy. ^[1] Department of Neurology, Hospital General Universitario Gregorio Marañon, Madrid, Spain. ^[2] Bayer AG, Wuppertal, Germany. ^[3] Bayer, Whippany, New Jersey, NY, USA. ^[4]

关键词 adherence autoinjector disease?-modifying therapy interferon beta-1b multiple sclerosis

DOI 10.2147/PPA.S245955

PMID 32425509

发布时间 2024-03-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Patient preference and adherence

2020年14卷

771-779页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

BetaEval Global: Prospective, Multinational, Observational Cohort Study of Patients Using BETACONNECT<sup>®</sup>.

Patient preference and adherence

相似文献

Patient preference and adherence

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

BetaEval Global: Prospective, Multinational, Observational Cohort Study of Patients Using BETACONNECT<sup>®</sup>.

Patient preference and adherence

相似文献

Patient preference and adherence

相关期刊

检索历史清除